Tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate
C23H26FN3O4 — CID 171048793
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate
Tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate (PubChem CID 171048793) has the molecular formula C23H26FN3O4 and a molecular weight of 427.48 g/mol. Its IUPAC name is tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate |
|---|---|
| PubChem CID | 171048793 |
| Molecular Formula | C23H26FN3O4 |
| Molecular Weight | 427.48 g/mol |
| Exact Mass | 427.19 |
| IUPAC Name | tert-butyl N-[(2S)-1-amino-3-[2-(4-fluorobenzoyl)-1,3-dihydroisoindol-5-yl]-1-oxopropan-2-yl]carbamate |
| SMILES | CC(C)(C)OC(=O)N[C@@H](Cc1ccc2c(c1)CN(C(=O)c1ccc(F)cc1)C2)C(N)=O |
| InChI | InChI=1S/C23H26FN3O4/c1-23(2,3)31-22(30)26-19(20(25)28)11-14-4-5-16-12-27(13-17(16)10-14)21(29)15-6-8-18(24)9-7-15/h4-10,19H,11-13H2,1-3H3,(H2,25,28)(H,26,30)/t19-/m0/s1 |
| InChIKey | MGHCGDXOQXIWIA-IBGZPJMESA-N |
| XLogP | 2.90 |
| TPSA | 101.73 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.48 |
| LogP ≤ 5 | 2.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171048793 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.